METHODS AND KITS FOR DETECTING OVARIAN CANCER FROM BLOOD

摘要

The complexity of the human plasma proteome represents a substantial challenge for discovery of diagnostic methods. Described herein is a method of contacting blood of a subject with at least one antibody to measure plasma levels of at least one protein selected from the group consisting of GRN, IGFBP2, TGFB1, THBSl, RARRES2, LCN2, TIMP1, and CD14. A computer is useful for transforming antibody reactivity into a value for blood level. The plasma levels of these proteins are useful to select a therapy suitable for subjects with ovarian cancer, or for monitoring efficacy of the therapy. Also described is a method of manufacturing a report in a tangible medium describing said level of said protein.